France Pharmaceuticals

Sanofi SA (SAN)

Track

Over the past 90 days, Sanofi SA has seen five planned purchase transactions by four members of the executive committee, totaling approximately 22,683 EUR. These acquisitions occurred following the company's July 2026 earnings report, where it reported a 10% earnings beat. The stock has experienced a 1.9% price change over the last three months.
Ticker: SAN Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Sanofi SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Thomas TRIOMPHE Membre du Comité Exécutif Officer
Transaction date
Planned purchase
Price
67.92
Quantity 22,549
Value €613,733
2.4
François-Xavier ROGER Membre du Comité Exécutif Officer
Transaction date
Planned purchase
Price
205.72
Quantity 60,680
Value €4,215,904
2.4
François-Xavier ROGER Membre du Comité Exécutif Officer
Transaction date
Planned purchase
Price
323.07
Quantity 79,897
Value €4,148,526
Emmanuel FRENEHARD Membre du Comité Exécutif Officer
Transaction date
Planned purchase
Price
76.44
Quantity 56
Value €4,296
3.7
Audrey DUVAL Membre du Comité Exécutif Officer
Transaction date
Planned purchase
Price
76.44
Quantity 27
Value €2,040
3.7
Anne-Françoise Nesmes Administrateur Director
Transaction date
Purchase
Price
79.09
Quantity 207
Value ¤16,371
3.3
Clotilde DELBOS Administrateur Director
Transaction date
Purchase
Price
82.70
Quantity 500
Value €41,350
2.8
Wolfgang Laux Administrateur représentant les salariés Director
Transaction date
Purchase
Price
72.97
Quantity 300
Value €21,891
2.8
Wolfgang Laux Administrateur représentant les salariés Director
Transaction date
Purchase
Price
88.27
Quantity 7
Value €600
John Sundy Director Director
Transaction date
Purchase
Price
55.03
Quantity 1,000
Value US$55,025
Jean-Paul Kress Director Director
Transaction date
Purchase
Price
53.12
Quantity 2,000
Value €106,230
3.3
Clotilde DELBOS Administrateur Director
Transaction date
Purchase
Price
97.53
Quantity 500
Value €48,765
3.7
Anne-Françoise Nesmes Administrateur Director
Transaction date
Purchase
Price
87.02
Quantity 533
Value €46,380
John Sundy Director Director
Transaction date
Purchase
Price
46.94
Quantity 887
Value US$41,638
John Sundy Director Director
Transaction date
Purchase
Price
46.94
Quantity 887
Value €41,638
3.7
Antoine Yver Administrateur Director
Transaction date
Purchase
Price
91.38
Quantity 1,000
Value €91,380
2.2
Emile Voest Director Director
Transaction date
Purchase
Price
92.54
Quantity 500
Value €46,272
2.8
Wolfgang Laux Administrateur représentant les salariés Director
Transaction date
Purchase
Price
79.58
Quantity 250
Value €19,895
2.8
Wolfgang Laux Administrateur représentant les salariés Director
Transaction date
Purchase
Price
95.12
Quantity 10
Value €926
3.0
Frédéric Oudéa Censeur
Transaction date
Purchase
Price
97.67
Quantity 500
Value €48,835
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-06 PP Planned purchase
Thomas TRIOMPHE

Membre du Comité Exécutif

Officer
22,549
67.92
€613,733 		22,549 67.92 €613,733
2026-06-08 2026-06-06 PP Planned purchase
2.4
François-Xavier ROGER

Membre du Comité Exécutif

Officer
60,680
205.72
€4,215,904 		60,680 205.72 €4,215,904
2026-06-05 2026-05-31 PP Planned purchase
2.4
François-Xavier ROGER

Membre du Comité Exécutif

Officer
79,897
323.07
€4,148,526 		79,897 323.07 €4,148,526
2026-06-05 2026-05-31 PP Planned purchase
Emmanuel FRENEHARD

Membre du Comité Exécutif

Officer
56
76.44
€4,296 		56 76.44 €4,296
2026-06-04 2026-05-31 PP Planned purchase
3.7
Audrey DUVAL

Membre du Comité Exécutif

Officer
27
76.44
€2,040 		27 76.44 €2,040
2025-11-13 2025-11-13 B Purchase
3.7
Anne-Françoise Nesmes

Administrateur

Director
207
79.09
¤16,371 		207 79.09 ¤16,371
2025-06-30 2025-06-26 B Purchase
3.3
Clotilde DELBOS

Administrateur

Director
500
82.70
€41,350 		500 82.70 €41,350
2025-07-28 2025-06-06 B Purchase
2.8
Wolfgang Laux

Administrateur représentant les salariés

Director
300
72.97
€21,891 		300 72.97 €21,891
2025-07-28 2025-06-06 B Purchase
2.8
Wolfgang Laux

Administrateur représentant les salariés

Director
7
88.27
€600 		7 88.27 €600
2025-04-03 2025-04-02 B Purchase
John Sundy

Director

Director
1,000
55.03
US$55,025 		1,000 55.03 US$55,025
2025-02-06 2025-02-05 B Purchase
Jean-Paul Kress

Director

Director
2,000
53.12
€106,230 		2,000 53.12 €106,230
2024-11-04 2024-10-31 B Purchase
3.3
Clotilde DELBOS

Administrateur

Director
500
97.53
€48,765 		500 97.53 €48,765
2024-09-18 2024-09-16 B Purchase
3.7
Anne-Françoise Nesmes

Administrateur

Director
533
87.02
€46,380 		533 87.02 €46,380
2024-06-27 2024-06-21 B Purchase
John Sundy

Director

Director
887
46.94
US$41,638 		887 46.94 US$41,638
2024-06-26 2024-06-21 B Purchase
John Sundy

Director

Director
887
46.94
€41,638 		887 46.94 €41,638
2024-04-30 2024-04-26 B Purchase
3.7
Antoine Yver

Administrateur

Director
1,000
91.38
€91,380 		1,000 91.38 €91,380
2024-05-22 2023-08-03 B Purchase
2.2
Emile Voest

Director

Director
500
92.54
€46,272 		500 92.54 €46,272
2023-07-24 2023-06-09 B Purchase
2.8
Wolfgang Laux

Administrateur représentant les salariés

Director
250
79.58
€19,895 		250 79.58 €19,895
2023-07-24 2023-06-09 B Purchase
2.8
Wolfgang Laux

Administrateur représentant les salariés

Director
10
95.12
€926 		10 95.12 €926
2023-05-04 2023-05-02 B Purchase
3.0
Frédéric Oudéa

Censeur
500
97.67
€48,835 		500 97.67 €48,835
Explore more

More insider trading research around Sanofi SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600